{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:52:53Z","timestamp":1770043973972,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nucmedbio.2025.109571","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:26:14Z","timestamp":1760145974000},"page":"109571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Illuminating radionuclide therapy response: Monitoring cancer cell and CAF survival in a direct 2D co-culture model"],"prefix":"10.1016","volume":"150-151","author":[{"given":"Circe D.","family":"van der Heide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roisin","family":"McMorrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Gama-Franceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michail","family":"Doukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mezzanotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone U.","family":"Dalm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2025.109571_bb0005","doi-asserted-by":"crossref","DOI":"10.1097\/CEJ.0000000000000594","article-title":"Progress in cancer mortality, incidence, and survival: a global overview","volume":"29","author":"Santucci","year":"2020","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4251\/wjgo.v8.i3.248","article-title":"Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival","volume":"8","author":"Sinn","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21037\/tgh.2019.03.05","article-title":"Treatment of pancreatic cancer-neoadjuvant treatment in resectable pancreatic cancer (PDAC)","volume":"4","author":"Seufferlein","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0025","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","article-title":"Metastatic and triple-negative breast cancer: challenges and treatment options","volume":"8","author":"Al-Mahmood","year":"2018","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109571_bb0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/ph12030114","article-title":"Lutathera\u00ae: the first FDA- and EMA-approved radiopharmaceutical for peptide receptor radionuclide therapy","volume":"12","author":"Hennrich","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0035","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.nucmedbio.2025.109571_bb0040","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/ph15101292","article-title":"[177Lu]Lu-PSMA-617 (PluvictoTM): the first FDA-approved radiotherapeutical for treatment of prostate cancer","volume":"15","author":"Hennrich","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0045","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0050","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0055","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00259-023-06144-0","article-title":"Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies","volume":"50","author":"Priv\u00e9","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0060","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","article-title":"Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy","volume":"49","author":"Zboralski","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.nucmedbio.2025.109571_bb0065","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2967\/jnumed.124.268200","article-title":"Preclinical evaluation of 177Lu-OncoFAP-23, a multivalent FAP-targeted radiopharmaceutical therapeutic for solid tumors","volume":"65","author":"Galbiati","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0070","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","article-title":"Development of fibroblast activation protein-targeted radiotracers with improved tumor retention","volume":"60","author":"Loktev","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0075","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2967\/jnumed.122.264036","article-title":"A dimeric FAP-targeting small-molecule radioconjugate with high and prolonged tumor uptake","volume":"63","author":"Galbiati","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0080","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101852118","article-title":"An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications","volume":"118","author":"Millul","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0085","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s41181-024-00283-x","article-title":"In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions","volume":"9","author":"van der Heide","year":"2024","journal-title":"EJNMMI Radiopharmacy and Chemistry"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.actbio.2024.10.031","article-title":"2D co-culture model reveals a biophysical interplay between activated fibroblasts and cancer cells","volume":"190","author":"Santos","year":"2024","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12935-020-01718-6","article-title":"CAFs affect the proliferation and treatment response of head and neck cancer spheroids during co-culturing in a unique in vitro model","volume":"20","author":"Magan","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajpath.2011.03.015","article-title":"Modeling colon adenocarcinomas in vitro: a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction","volume":"179","author":"Dolznig","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1053920","article-title":"Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer","volume":"14","author":"Strating","year":"2023","journal-title":"Front Immunol"},{"issue":"15","key":"10.1016\/j.nucmedbio.2025.109571_bb0120","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3390\/cancers14153586","article-title":"Potential of gold nanoparticles in current radiotherapy using a co-culture model of cancer cells and cancer associated fibroblasts","volume":"14","author":"Alhussan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70240","article-title":"Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models","volume":"13","author":"Afshan","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41467-017-02542-9","article-title":"Click beetle luciferase mutant and near infrared naphthyl-luciferins for improved bioluminescence imaging","volume":"9","author":"Hall","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0135","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Stewart","year":"2003","journal-title":"Rna"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019277","article-title":"Sensitive dual color in vivo bioluminescence imaging using a new red codon optimized firefly luciferase and a green click beetle luciferase","volume":"6","author":"Mezzanotte","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-0037-1613457","article-title":"Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression","volume":"89","author":"Martens","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0155","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11307-020-01523-7","article-title":"Evaluating brightness and spectral properties of click beetle and firefly luciferases using luciferin analogues: identification of preferred pairings of luciferase and substrate for in vivo bioluminescence imaging","volume":"22","author":"Zambito","year":"2020","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0160","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0165","article-title":"Molecular optical imaging with radioactive probes","volume":"5","author":"Liu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0170","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41598-023-50877-9","article-title":"Radiation-induced changes in energy metabolism result in mitochondrial dysfunction in salivary glands","volume":"14","author":"Buss","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mc.23379","article-title":"Metabolic response to radiation therapy in cancer","volume":"61","author":"Read","year":"2022","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0180","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3389\/fmolb.2019.00070","article-title":"Impact of cancer-associated fibroblast on the radiation-response of solid xenograft tumors","volume":"6","author":"Steer","year":"2019","journal-title":"Front Mol Biosci"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109571_bb0185","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/biomedicines11061773","article-title":"The effect of radiotherapy on cell survival and inflammatory cytokine and chemokine secretion in a co-culture model of head and neck squamous cell carcinoma and Normal cells","volume":"11","author":"Matuszczak","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0190","first-page":"14","article-title":"Modeling the role of cancer-associated fibroblasts in tumor cell invasion","author":"Poon","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0195","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrc.2018.15","article-title":"Cell motility in cancer invasion and metastasis: insights from simple model organisms","volume":"18","author":"Stuelten","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.867164","article-title":"Near-infrared bioluminescence imaging of macrophage sensors for cancer detection in vivo","volume":"10","author":"Zambito","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0205","article-title":"A dual-luciferase bioluminescence system for the assessment of cellular therapies","volume":"32","author":"Torres Chavez","year":"2024","journal-title":"Mol Ther Oncol"},{"key":"10.1016\/j.nucmedbio.2025.109571_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115510","article-title":"Bioluminescence imaging on-chip platforms for non-invasive high-content bioimaging","volume":"237","author":"Ara\u00fajo-Gomes","year":"2023","journal-title":"Biosens Bioelectron"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109571_bb0215","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1007\/s00259-025-07123-3","article-title":"Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics","volume":"52","author":"Bokhout","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.nucmedbio.2025.109571_bb0220","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/cells12101420","article-title":"Fibroblast activation protein-targeting minibody-IRDye700DX for ablation of the cancer-associated fibroblast with photodynamic therapy","volume":"12","author":"Smeets","year":"2023","journal-title":"Cells"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125005803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125005803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:07:18Z","timestamp":1764346038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805125005803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"alternative-id":["S0969805125005803"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109571","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Illuminating radionuclide therapy response: Monitoring cancer cell and CAF survival in a direct 2D co-culture model","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109571"}}